PEGylated rFVIII in Severe Haemophilia A Patients Undergoing Surgery
Research type
Research Study
Full title
A Phase 3, Multi-Center, Open Label Study of Efficacy and Safety of PEGylated rFVIII (BAX 855) in Previously Treated Patients With Severe Hemophilia A Undergoing Surgical or Other Invasive Procedures
IRAS ID
131147
Contact name
Andrew Will
Contact email
Sponsor organisation
Baxter Innovations GmbH
Eudract number
2013-001359-11
REC name
East of Scotland Research Ethics Service REC 2
REC reference
13/ES/0103
Date of REC Opinion
17 Dec 2013
REC opinion
Further Information Favourable Opinion